Ursodiol 300 MG Oral Capsule — RxCUI 858747
RxNorm drug concept · Semantic clinical drug
RxCUI 858747
Semantic clinical drug · SCD
● Current RxNorm concept 23 FDA products
28 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI858747
Official nameUrsodiol 300 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped23
Package NDCs mapped28
Reported Medicaid activity (SDUD)111,388 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ursodiol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the product. Ursodiol capsules are used to dissolve certain cholesterol gallstones and to prevent gallstones during rapid weight loss. Urso 250, Urso Forte, and ursod...
- It’s taken by mouth. For gallstones, capsules are usually divided into 2 or 3 doses a day. For PBC, tablets are taken in two to four divided doses with food. Follow your prescripti...
- Stomach-related effects are the most common, such as belly pain, diarrhea, constipation, and nausea. Headache and dizziness can also happen. Call your doctor about severe belly pai...
- Yes. Cholestyramine, colestipol, and aluminum-based antacids may reduce how much ursodiol works. Estrogens, birth control pills, and clofibrate can work against it for gallstones....
🕸️ Concept Web — How Ursodiol 300 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ursodiol 300 MG Oral Capsule
RxCUI 858747 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Ursodeoxycholate
62427IN -
Ursodiol
11065PIN
-
Ursodeoxycholate
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ursodeoxycholate Oral Capsule
618512SCDF -
Ursodiol Oral Capsule
2645659SCDFP -
Ursodeoxycholate Oral Product
1159985SCDG -
Ursodeoxycholate Pill
1159986SCDG -
Ursodiol Oral Product
2662119SCDGP -
Ursodiol Pill
2660380SCDGP -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Ursodeoxycholate Oral Capsule
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ursodiol 300 MG
858328SCDC
-
Ursodiol 300 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ursodiol 300 MG
SCDC · 858328 -
Ursodeoxycholate Oral Capsule
SCDF · 618512 -
Ursodiol Oral Capsule
SCDFP · 2645659 -
Ursodeoxycholate Oral Product
SCDG · 1159985 -
Ursodeoxycholate Pill
SCDG · 1159986 -
Ursodiol Oral Product
SCDGP · 2662119 -
Ursodiol Pill
SCDGP · 2660380
📦 FDA Products & Package NDCs
23 products · 28 package NDCs
28 package NDCs map to RxCUI 858747 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00527-1326-01 | 100 CAPSULE in 1 BOTTLE (0527-1326-01) | Ursodiol | Lannett Company, Inc. | 2009-01-01 |
| 00591-3159-01 | 100 CAPSULE in 1 BOTTLE (0591-3159-01) | Ursodiol | Actavis Pharma, Inc. | 1987-12-31 |
| 00904-6221-06 | 50 BLISTER PACK in 1 CARTON (0904-6221-06) / 1 CAPSULE in 1... | Ursodiol | Major Pharmaceuticals | 2011-04-01 |
| 00904-6221-61 | 100 BLISTER PACK in 1 CARTON (0904-6221-61) / 1 CAPSULE in... | Ursodiol | Major Pharmaceuticals | 2011-04-01 |
| 10702-0237-01 | 100 CAPSULE in 1 BOTTLE (10702-237-01) | Ursodiol | KVK-Tech, Inc. | 2018-05-17 |
| 24658-0780-01 | 100 CAPSULE in 1 BOTTLE (24658-780-01) | Ursodiol | PuraCap Laboratories, LLC | 2016-12-15 |
| 24658-0999-10 | 1000 CAPSULE in 1 BOTTLE (24658-999-10) | Ursodiol | PuraCap Laboratories, LLC | 2021-09-30 |
| 42291-0923-01 | 100 CAPSULE in 1 BOTTLE (42291-923-01) | Ursodiol | AvKARE | 2023-07-18 |
| 42385-0946-01 | 100 CAPSULE in 1 BOTTLE (42385-946-01) | Ursodiol | Laurus Labs Limited | 2021-04-17 |
| 42806-0503-01 | 100 CAPSULE in 1 BOTTLE (42806-503-01) | Ursodiol | Epic Pharma, LLC | 2010-07-16 |
| 43063-0871-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (43063-871-01) | Ursodiol | PD-Rx Pharmaceuticals, Inc. | 2018-07-26 |
| 43063-0871-60 | 60 CAPSULE in 1 BOTTLE, PLASTIC (43063-871-60) | Ursodiol | PD-Rx Pharmaceuticals, Inc. | 2019-12-10 |
| 43063-0871-93 | 180 CAPSULE in 1 BOTTLE, PLASTIC (43063-871-93) | Ursodiol | PD-Rx Pharmaceuticals, Inc. | 2019-12-10 |
| 50268-0797-15 | 50 BLISTER PACK in 1 BOX (50268-797-15) / 1 CAPSULE in 1 BL... | Ursodiol | AvPAK | 2021-02-19 |
| 51407-0754-01 | 100 CAPSULE in 1 BOTTLE (51407-754-01) | URSODIOL | Golden State Medical Supply, Inc. | 2023-05-05 |
| 59651-0421-01 | 100 CAPSULE in 1 BOTTLE (59651-421-01) | Ursodiol | Aurobindo Pharma Limited | 2022-11-28 |
| 60687-0100-01 | 100 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-100-01) / 1 CAP... | Ursodiol | American Health Packaging | 2015-05-12 |
| 62135-0430-60 | 60 CAPSULE in 1 BOTTLE (62135-430-60) | Ursodiol | Chartwell RX, LLC | 2023-01-03 |
| 64380-0844-04 | 30 CAPSULE in 1 BOTTLE (64380-844-04) | URSODIOL | Strides Pharma Science Limited | 2021-09-13 |
| 64380-0844-06 | 100 CAPSULE in 1 BOTTLE (64380-844-06) | URSODIOL | Strides Pharma Science Limited | 2021-09-13 |
| 64380-0844-07 | 500 CAPSULE in 1 BOTTLE (64380-844-07) | URSODIOL | Strides Pharma Science Limited | 2021-09-13 |
| 69238-1540-01 | 100 CAPSULE in 1 BOTTLE (69238-1540-1) | Ursodiol | Amneal Pharmaceuticals NY LLC | 2018-10-22 |
| 70710-1483-01 | 100 CAPSULE in 1 BOTTLE (70710-1483-1) | Ursodiol | Zydus Pharmaceuticals (USA) Inc. | 2021-01-21 |
| 70771-1524-01 | 100 CAPSULE in 1 BOTTLE (70771-1524-1) | Ursodiol | Zydus Lifesciences Limited | 2021-01-21 |
| 72162-2168-01 | 100 CAPSULE in 1 BOTTLE (72162-2168-1) | Ursodiol | Bryant Ranch Prepack | 2023-12-07 |
| 72162-2619-01 | 100 CAPSULE in 1 BOTTLE (72162-2619-1) | Ursodiol | Bryant Ranch Prepack | 2026-04-20 |
| 72603-0613-01 | 100 CAPSULE in 1 BOTTLE (72603-613-01) | Ursodiol | NorthStar Rx LLC | 2025-05-01 |
| 72664-0217-01 | 100 CAPSULE in 1 BOTTLE, PLASTIC (72664-217-01) | Ursodiol | VGYAAN Pharmaceuticals LLC | 2020-10-25 |
Observed labelers:
PD-Rx Pharmaceuticals, Inc. (3) ·
Strides Pharma Science Limited (3) ·
Bryant Ranch Prepack (2) ·
Major Pharmaceuticals (2) ·
PuraCap Laboratories, LLC (2) ·
Actavis Pharma, Inc. (1)
· +15 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.